BBHC
FBT icon

Brown Brothers Harriman & Co’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Brown Brothers Harriman & Co’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-50
Closed -$7K – 1528
2022
Q2 		$7K Buy
+50
New +$6.89K ﹤0.01% 1072

Other funds holding FBT

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.65B AUM 29.37% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Brown Brothers Harriman & Co's FBT Position: Q3 2022 in Review

Brown Brothers Harriman & Co sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2022, closing a stake of 50 shares — an estimated $7K sold.

Brown Brothers Harriman & Co first reported a position in FBT in Q2 2022 and held it in 1 quarter. The position peaked at $7K in Q2 2022. 217 funds tracked by Wall St. Rank hold FBT as of Q3 2022.

  • Brown Brothers Harriman & Co reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2022 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 50 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2022, an estimated $7K.
  • Brown Brothers Harriman & Co first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2022 and held it in 1 quarter.
  • Brown Brothers Harriman & Co's First Trust NYSE Arca Biotechnology Index Fund position peaked at $7K in Q2 2022.
  • 217 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2022.

Based on Brown Brothers Harriman & Co's 13F filing for Q3 2022, filed 14 Nov 2022.